Toll-like receptor ligands reverse suppression of contact hypersensitivity reactions induced by epicutaneous immunization with protein antigen

International Archives of Allergy and Immunology

Volumn 139, Issue 3, 2006, Pages 188-200

  Ptak, Włodzimierz ^a   Bryniarski, Krzysztof ^a   Ptak, Maria ^a   Majewska, Monika ^a   Gamian, Andrzej ^b   Lobo, Francis M ^c   Szczepanik, Marian ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Epicutaneous immunization; Toll like receptor

Indexed keywords

BACTERIUM LYSATE; CROSS REACTING ANTIGEN; CYTOKINE; HAPTEN; LIPOPOLYSACCHARIDE; RECOMBINANT ANTIGEN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TRINITROPHENYL IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN SPECIFICITY; ARTICLE; CELL POPULATION; CONTACT SENSITIVITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION; IMMUNOCOMPETENT CELL; INHIBITION KINETICS; LYMPH NODE CELL; MALE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SUPPRESSOR CELL;

ANIMALS; ANTIGENS; CYTOKINES; DERMATITIS, CONTACT; EPITOPES; IMMUNIZATION; LIGANDS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C3H; MICE, INBRED CBA; OXAZOLONE; SKIN; T-LYMPHOCYTES; TOLL-LIKE RECEPTORS; TRINITROBENZENES;

EID: 33344467248     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000091164     Document Type: Article

References (34)

1. Tsuji RF, Szczepanik M, Kavikowa I, Paliwal V, Campos RA, Funakoshi A, Akahira-Azuma M, Baumgarth N, Herzenberg L, Askenase PW: B cell-dependent T cell responses: IgM antibodies are required to elicit contact sensitivity. J Exp Med 2002;196:1277-1290.
2. Campos R, Szczepanik M, Akahira-Azuma M, Kronenberg M, Askenase PW: Liver NK-T cells are activated early in contact sensitivity (CS) and release IL-4 that activate B-1 cells that are involved in initiation of CS. J Exp Med 2003;198:1-12.
3. Szczepanik M, Akahira-Azuma M, Bryniarski K, Tsuji RF, Kawikova I, Campos RA, Ptak W, Askenase PW: B-1 cells mediate required early T cell recruitment to elicit protein induced delayed-type hypersensitivity. J Immunol 2003;171:6225-6235.
4. Ptak W, Szczepanik M, Bryniarski K, Tutaj M, Ptak M: Epicutaneous application of protein antigens incorporated into cosmetic cream induces antigen-nonspecific unresponsiveness in mice and affects the cell-mediated immune response. Int Arch Allergy Immunol 2000;128:8-14.
5. Szczepanik M: Skin induced tolerance and its clinical implications. Mod Aspects Immunobiol 2002;2:265-268.
6. Szczepanik M, Bryniarski K, Tutaj M, Ptak M, Skrzeczyńska J, Askenase PW, Ptak W: Epicutaneous immunisation with protein antigen induces αβ-TCR CD4 CD8 double positive non-specific suppressor cells that inhibit contact sensitivity and the in vitro cell mediated immune response via TGF-β production. Immunology 2005;115:42-54.
7. Różycka D, Ptak W: Split unresponsiveness to trinitrophenyl (TNP) determinant. Suppression of anti-TNP antibody responses by sensitization with picryl chloride. Immunology 1978;35:229-235.
8. Szczepanik M: Regulation of contact hypersensitivity responses by different populations of T suppressor cells. Skin induced tolerance and its clinical implication. Recent Res Dev Immunol 2002;4:641-668.
9. Szczepanik M, Tutaj M, Bryniarski K, Dittel BN: Epicutaneously induced TGF-β-dependent tolerance inhibits experimental autoimmune encephalomyelitis. J Neuroimmunol 2005;164:105-114.
10. Janeway CA Jr, Medzhitov R: Innate immune recognition. Annu Rev Immunol 2002;20:197-216.
11. Hirschfeld M, Kirschning CJ, Schwandner R, Wesche H, Weis JH, Wooten RM, Weis JJ: Inflammatory signaling by Borelia burgdorferi lipoproteins is mediated by toll-like receptor 2. J Immunol 1999;163:2382-2386.
12. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Willson CB, Bassetti M, Aderem A: The toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 1999;401:811-815.
13. Werts C, Tapping RI, Mathison JC, et al: Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat Immunol 2001;2:346-352.
14. Darveau RP, Pham TT, Lemley K, Reife RA, Bainbridge BW, Coats SR, Howald WN, Way SS, Hajjar AM: Porphyromonas gingivalis lipopolysaccharide contains multiple lipid A species that functionally interact with both toll-like receptors 2 and 4. Infect Immun 2004;72:5041-5051.
15. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, Takeda Y, Takeda K, Akira S: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J Immunol 1999;162:3749-3752.
16. Takeda K, Akira S: Microbial recognition by Toll-like receptors. J Dermatol Sci 2004;34:73-82.
17. Smith KD, Andersen-Nissen E, Hayashi F, Strobe K, Bergman MA, Barrett SL, Cookson BT, Aderem A: Toll-like receptor 5 recognizes a conserved site on flagellin required for protofilament formation and bacterial motility. Nat Immunol 2003;4:1247-1253.
18. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H, Matsumoto M, Hoshino K, Wagner H, Takeda K, Akira S: A Toll-like receptor recognizes bacterial DNA. Nature 2000;408:740-745.
19. Ptak W, Flood PM, Janeway CA Jr, Green DR: Immunoregulatory role of Ig isotypes. I. Induction of contrasuppressor T cells for contact sensitivity responses by antibodies of the IgM, IgG1, and IgG3 isotypes. J Immunol 1988;141:756-764.
20. Mc Kinney M, Parkinson A: A single non-chromatographic procedure to purify immunoglobulins from serum and ascites. J Immunol Methods 1987;96:271-278.
21. Little JR, Eisen HN: Preparation and characterization of antibodies specific for the 2,4,6-trinitro group. Biochemistry 1966;5:3385-3395.
22. Askenase PW, Asherson GL: Contact sensitivity to oxazolone in the mouse. VIII. Demonstration of several classes of antibody in the sera of contact sensitized and unimmunized mice by a simplified antiglobulin assay. Immunology 1972;27:206-214.
23. Westphal O, Jann K: Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure. Methods Carbohydr Chem 1965;5:83-91.
24. Chesneau O, Morvan A, Grimont F, Labischinski H, El Sohl N: Staphylococcus pasteuri sp. nov., isolated from human, animal, and food specimens. Int J Syst Bacteriol 1993;43:237-244.
25. Mack D, Nedelmann M, Krokotsch A, Schwarzkopf A, Heesemann J, Laufs R: Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin. Infect Immunol 1994;62:3244-3253.
26. Fykse EM, Olsen JS, Skogan G: Application of sonication to release DNA from Bacillus cereus for quantitative detection by real-time PCR. J Microbiol Methods 2003;55:1-10.
27. Poltorak A, Xiaolong H, Smirnova I, Liu MY, et al: Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998;282:2085-2088.
28. Green DR, Ptak W: Contrasuppression in the mouse. Immunol Today 1986;7:81-86.
29. Kubo T, Hatton RD, Olivier J, Liu X, Elson CO, Weaver CT: Regulatory T cell suppression and anergy are differentially regulated by pro-inflammatory cytokines produced by TLR-activated dendritic cells. J Immunol 2004;173:7249-7258.
30. Britz JS, Askenase PW, Ptak W, Steinman RM, Gershon RK: Specialized antigen-presenting cells. Splenic dendritic cells and peritoneal-exudate cells induced by Mycobacteria activate effector cells that are resistant to suppression. J Exp Med 1982;155:1344-1356.
31. Pasare C, Medzhitov R: Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003;299:1033-1036.
32. Palival V, Friedman AM, Ptak W, Askenase PW: Monoclonal, antigen-specific, T cell contrasuppressor factor expresses determinants of TCR α-chain (not necessarily β-chain), having a molecular mass of about 40 kDa. J Immunol 1994;152:2811-2820.
33. Turk MJ, Guevara-Patino JA, Rizzuto GA, Engelhorn ME, Houghton AN: Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J Exp Med 2004;200:771-782.
34. Berendt M, North RJ: T-cell-mediated suppression of antitumor immunity. An explanation for progressive growth of an immunogenic tumor. J Exp Med 1980;151:69-80.